Chat with us
Research Assistance
Online
  • Please enter your first name.

Saudi Arabia Psoriasis Drugs Market Size & Outlook

The psoriasis drugs market in Saudi Arabia is expected to reach a projected revenue of US$ 283.1 million by 2033. A compound annual growth rate of 13.5% is expected of Saudi Arabia psoriasis drugs market from 2026 to 2033.

  • Pharmaceuticals
    • Skin Care Treatment
      • Psoriasis Drugs Market Outlook
Revenue, 2025 (US$M)
$104.1
Estimate, 2026 (US$M)
$117.0
Forecast, 2033 (US$M)
$283.1
CAGR, 2026 - 2033
13.5%
Prism AI by Grand View ResearchFree to try

Ask a question about the psoriasis drugs market

Every figure cited from GVR research

Saudi Arabia psoriasis drugs market highlights

  • The Saudi Arabia psoriasis drugs market generated a revenue of USD 104.1 million in 2025 and is expected to reach USD 283.1 million by 2033.
  • The Saudi Arabia market is expected to grow at a CAGR of 13.5% from 2026 to 2033.
  • In terms of segment, tumor necrosis factor inhibitors was the largest revenue generating class in 2025.
  • Interleukin Inhibitors is the most lucrative class segment registering the fastest growth during the forecast period.


Psoriasis drugs market data book summary

Market revenue in 2025USD 104.1 million
Market revenue in 2033USD 283.1 million
Growth rate13.5% (CAGR from 2026 to 2033)
Largest segmentTumor necrosis factor inhibitors
Fastest growing segmentInterleukin Inhibitors
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationTumor Necrosis Factor Inhibitors, Interleukin Inhibitors, Vitamin-D Analogues, Corticosteriods
Key market players worldwideAbbVie Inc, Amgen Inc, Johnson & Johnson Services, Inc., Novartis AG, Eli Lilly and Company, AstraZeneca PLC, Celgene Corporation, UCB SA, Merck KGaA, Boehringer Ingelheim International GmbH


Other key industry trends

  • In terms of revenue, Saudi Arabia accounted for 0.4% of the global psoriasis drugs market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, South Africa psoriasis drugs market is projected to lead the regional market in terms of revenue in 2033.
  • Kuwait is the fastest growing regional market in Middle East & Africa and is projected to reach USD 127.5 million by 2033.

No credit card required*

Publish Date: Jul 23, 2026

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Psoriasis Drugs Market Companies

NameProfile# EmployeesHQWebsite
Amgen IncView profile 26,700One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799www.amgen.com
Merck KGaAView profile 62,345Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293www.emdgroup.com
AbbVie IncView profile 50,0001 North Waukegan Road, North Chicago, IL, United States, 60064-6400www.abbvieinvestor.com
UCB SAView profile 9,083Allee de la Recherche, 60, Brussels, Belgium, B-1070www.ucb.com
AstraZeneca PLCView profile 89,9001 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AAwww.astrazeneca.com
Novartis AGView profile ---
Johnson & Johnson Services, Inc.View profile ---
Eli Lilly and CompanyView profile ---
Celgene CorporationView profile ---
Boehringer Ingelheim International GmbHView profile ---

Saudi Arabia Psoriasis Drugs Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Psoriasis Drugs Market Outlook will help companies and investors design strategic landscapes.


Tumor Necrosis Factor Inhibitors was the largest segment with a revenue share of 45.73% in 2025.

Horizon Databook has segmented the Saudi Arabia psoriasis drugs market based on tumor necrosis factor inhibitors, interleukin inhibitors, vitamin-d analogues, corticosteriods covering the revenue growth of each sub-segment from 2021 to 2033.


  • Saudi Arabia Psoriasis Drugs Market Class Outlook (Revenue, USD Million , 2021-2033)
    • Tumor Necrosis Factor Inhibitors
    • InterleU.S.in Inhibitors
    • Vitamin-D Analogues
    • Corticosteriods
    • Others
  • Saudi Arabia Psoriasis Drugs Market Treatment Outlook (Revenue, USD Million , 2021-2033)
    • Topicals
    • Systemic
    • Biologics
  • Saudi Arabia Psoriasis Drugs Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
    • Oral
    • Parenteral
    • Topical
  • Saudi Arabia Psoriasis Drugs Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Others

Reasons to subscribe to Psoriasis Drugs Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Psoriasis Drugs Market Outlook databook

  • Our clientele includes a mix of Psoriasis Drugs Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia Psoriasis Drugs Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia Psoriasis Drugs Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Saudi Arabia Psoriasis Drugs Market, 2021-2033 (US$M)

No Access Stack Chart

Saudi Arabia Class - Psoriasis Drugs Market Statistics, 2025 - 2033 (US$M)

No Access Pie Chart

Saudi Arabia Class - Psoriasis Drugs Market Statistics, 2025 - 2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more